245 related articles for article (PubMed ID: 33153280)
1. Monitoring of the Evolution of Immune Checkpoint Inhibitor Myocarditis With Cardiovascular Magnetic Resonance.
Sato T; Nakamori S; Watanabe S; Nishikawa K; Inoue T; Imanaka-Yoshida K; Ishida M; Sakuma H; Ito M; Dohi K
Circ Cardiovasc Imaging; 2020 Nov; 13(11):e010633. PubMed ID: 33153280
[No Abstract] [Full Text] [Related]
2. Subclinical Myocarditis After Combination Immune Checkpoint Inhibitor Therapy.
Giblin GT; Dennehy C; Featherstone H; Clarke R; Murphy L; Timlin D; O'Keane C; Mulligan N; Kelly CM; Joyce E
Circ Heart Fail; 2021 Feb; 14(2):e007524. PubMed ID: 33478241
[No Abstract] [Full Text] [Related]
3. Immune checkpoint inhibitors myocarditis: not all cases are clinically patent.
Thibault C; Vano Y; Soulat G; Mirabel M
Eur Heart J; 2018 Oct; 39(38):3553. PubMed ID: 30107497
[No Abstract] [Full Text] [Related]
4. Acute fatal myocarditis after a single dose of anti-PD-1 immunotherapy, autopsy findings: a case report.
Hardy T; Yin M; Chavez JA; Ivanov I; Chen W; Nadasdy T; Brodsky SV
Cardiovasc Pathol; 2020; 46():107202. PubMed ID: 32062109
[TBL] [Abstract][Full Text] [Related]
5. Myocarditis associated with immune checkpoint inhibitor therapy: a case report of three patients.
Ansari-Gilani K; Tirumani SH; Smith DA; Nelson A; Alahmadi A; Hoimes CJ; Ramaiya NH
Emerg Radiol; 2020 Aug; 27(4):455-460. PubMed ID: 32130542
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoint Inhibitor Myocarditis With Normal Cardiac Magnetic Resonance Imaging: Importance of Cardiac Biopsy and Early Diagnosis.
Ederhy S; Fenioux C; Cholet C; Rouvier P; Redheuil A; Cohen A; Salem JE
Can J Cardiol; 2021 Oct; 37(10):1654-1656. PubMed ID: 33373722
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging criteria of immune checkpoint inhibitor-induced hypophysitis.
Nada A; Bhat R; Cousins J
Curr Probl Cancer; 2021 Feb; 45(1):100644. PubMed ID: 32888700
[TBL] [Abstract][Full Text] [Related]
8. Management of immune checkpoint inhibitor myocarditis: a serial cardiovascular magnetic resonance T2 mapping approach.
Ida M; Nakamori S; Ishida M; Dohi K
Eur Heart J; 2021 Jul; 42(29):2869. PubMed ID: 34089601
[No Abstract] [Full Text] [Related]
9. Acute Myocarditis by Immune Checkpoint Inhibitor Identified by Quantitative Pixel-Wise Analysis of Native T1 Mapping.
Kato S; Fukui K; Kodama S; Azuma M; Nakayama N; Kishimoto M; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
Circ Cardiovasc Imaging; 2021 May; 14(5):e012177. PubMed ID: 33951932
[No Abstract] [Full Text] [Related]
10. Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.
Valenti-Azcarate R; Esparragosa Vazquez I; Toledano Illan C; Idoate Gastearena MA; Gállego Pérez-Larraya J
Neuromuscul Disord; 2020 Jan; 30(1):67-69. PubMed ID: 31839404
[TBL] [Abstract][Full Text] [Related]
11. First case of hemophagocytic lymphohistiocytosis secondary to cabozantinib with checkpoint inhibitors.
Azari AE; Stratton R; Singh A
Rheumatology (Oxford); 2021 May; 60(5):e167-e168. PubMed ID: 33280022
[No Abstract] [Full Text] [Related]
12. Acute tubulointerstitial nephritis and IgM deposits on glomerular capillary walls after immunotherapy with nivolumab for metastatic renal cell carcinoma.
Irifuku T; Satoh A; Tani H; Mandai K; Masaki T
CEN Case Rep; 2020 Feb; 9(1):48-54. PubMed ID: 31605271
[TBL] [Abstract][Full Text] [Related]
13. Renal damage secondary to check-point inhibitors.
Moliz C; Cavero T; Morales E; Gutiérrez E; Alonso M; Praga M
Nefrologia (Engl Ed); 2020; 40(2):206-208. PubMed ID: 31615688
[No Abstract] [Full Text] [Related]
14. Association of thrombotic microangiopathy with atezolizumab therapy in cancer patients.
Izzedine H; Mathian A; Albiges L; Champiat S; Brocheriou I
Eur J Cancer; 2021 May; 149():34-36. PubMed ID: 33819719
[No Abstract] [Full Text] [Related]
15. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy.
Balanescu DV; Donisan T; Palaskas N; Lopez-Mattei J; Kim PY; Buja LM; McNamara DM; Kobashigawa JA; Durand JB; Iliescu CA
Cardiovasc Pathol; 2020; 47():107211. PubMed ID: 32268262
[TBL] [Abstract][Full Text] [Related]
16. Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma.
Parikh M; Bajwa P
Semin Nephrol; 2020 Jan; 40(1):76-85. PubMed ID: 32130969
[TBL] [Abstract][Full Text] [Related]
17. Dermatomal necrotizing infundibular crystalline folliculitis following herpes zoster in a patient on PD-1 inhibitor therapy.
Fischer AS; Pei S; Shields BE; Rosenbach M; Rubin AI
J Cutan Pathol; 2020 Jun; 47(6):501-505. PubMed ID: 32428371
[No Abstract] [Full Text] [Related]
18. Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept.
Khene ZE; Mathieu R; Peyronnet B; Kokorian R; Gasmi A; Khene F; Rioux-Leclercq N; Kammerer-Jacquet SF; Shariat S; Laguerre B; Bensalah K
World J Urol; 2021 Sep; 39(9):3707-3709. PubMed ID: 32632555
[No Abstract] [Full Text] [Related]
19. Immune checkpoint inhibitor-mediated myasthenia gravis with focal subclinical myocarditis progressing to symptomatic cardiac disease.
Leaver PJ; Jang HS; Vernon ST; Fernando SL
BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32404371
[TBL] [Abstract][Full Text] [Related]
20. T1 Mapping Enabled Detection and Follow-up of Rare Immune Checkpoint Inhibitor Myocarditis.
Nishikawa Y; Takaoka H; Kanda M; Yumita S; Ogasawara S; Daimon M; Noguchi Y; Aoki S; Suzuki K; Yoshida K; Yashima S; Kinoshita M; Sasaki H; Suzuki-Eguchi N; Kato N; Kobayashi Y
Circ J; 2024 Jan; 88(2):259. PubMed ID: 38123297
[No Abstract] [Full Text] [Related]
[Next] [New Search]